Dimensional Fund Advisors
LRMR icon

Dimensional Fund Advisors’s Larimar Therapeutics LRMR Stock Holding History

Dimensional Fund Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
961,083
+162,621
+20% +$646K ﹤0.01% 2651
2026
Q1 		$3.59M Buy
798,462
+470,968
+144% +$1.88M ﹤0.01% 2588
2025
Q4 		$1.25M Buy
327,494
+271,237
+482% +$1.05M ﹤0.01% 2831
2025
Q3 		$182K Buy
56,257
+24,903
+79% +$93.4K ﹤0.01% 3130
2025
Q2 		$90.6K Sell
31,354
-41,295
-57% -$95.6K ﹤0.01% 3190
2025
Q1 		$156K Sell
72,649
-8,501
-10% -$26.9K ﹤0.01% 3154
2024
Q4 		$314K Sell
81,150
-25,753
-24% -$170K ﹤0.01% 3103
2024
Q3 		$700K Sell
106,903
-38,820
-27% -$312K ﹤0.01% 2974
2024
Q2 		$1.06M Sell
145,723
-30,021
-17% -$230K ﹤0.01% 2902
2024
Q1 		$1.33M Sell
175,744
-19,444
-10% -$152K ﹤0.01% 2872
2023
Q4 		$888K Sell
195,188
-29,038
-13% -$98K ﹤0.01% 2947
2023
Q3 		$888K Sell
224,226
-94,683
-30% -$358K ﹤0.01% 2948
2023
Q2 		$998K Buy
318,909
+153,467
+93% +$626K ﹤0.01% 2934
2023
Q1 		$749K Buy
+165,442
New +$864K ﹤0.01% 2959
2022
Q3 		$93K Buy
29,212
+4,474
+18% +$11.2K ﹤0.01% 3348
2022
Q2 		$48K Sell
24,738
-3,400
-12% -$10K ﹤0.01% 3390
2022
Q1 		$114K Hold
28,138
– – ﹤0.01% 3380
2021
Q4 		$304K Buy
28,138
+12,731
+83% +$142K ﹤0.01% 3270
2021
Q3 		$178K Buy
+15,407
New +$185K ﹤0.01% 3367
2021
Q2 		– Sell
-13,842
Closed -$202K – 3471
2021
Q1 		$202K Buy
+13,842
New +$251K ﹤0.01% 3289
2019
Q4 		– Sell
-55,268
Closed -$490K – 3398
2019
Q3 		$490K Sell
55,268
-33,763
-38% -$370K ﹤0.01% 3141
2019
Q2 		$1.27M Buy
89,031
+1,147
+1% +$30.6K ﹤0.01% 3001
2019
Q1 		$2.89M Buy
87,884
+12,534
+17% +$643K ﹤0.01% 2808
2018
Q4 		$4.48M Buy
75,350
+1,786
+2% +$176K ﹤0.01% 2646
2018
Q3 		$10.3M Sell
73,564
-2,661
-3% -$323K ﹤0.01% 2427
2018
Q2 		$9.36M Buy
76,225
+4,144
+6% +$352K ﹤0.01% 2453
2018
Q1 		$6.44M Buy
72,081
+14,540
+25% +$1.23M ﹤0.01% 2531
2017
Q4 		$3.19M Buy
57,541
+8,659
+18% +$390K ﹤0.01% 2754
2017
Q3 		$2.06M Buy
48,882
+202
+0.4% +$8.4K ﹤0.01% 2854
2017
Q2 		$2.05M Buy
48,680
+11,737
+32% +$600K ﹤0.01% 2843
2017
Q1 		$2.07M Buy
36,943
+11,404
+45% +$566K ﹤0.01% 2833
2016
Q4 		$975K Buy
25,539
+7,484
+41% +$304K ﹤0.01% 2969
2016
Q3 		$717K Buy
18,055
+16,406
+995% +$745K ﹤0.01% 2999
2016
Q2 		$119K Sell
1,649
-3,807
-70% -$301K ﹤0.01% 3225
2016
Q1 		$437K Sell
5,456
-1
-0% -$79 ﹤0.01% 3069
2015
Q4 		$412K Buy
+5,457
New +$877K ﹤0.01% 3129

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Dimensional Fund Advisors's LRMR Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Larimar Therapeutics (LRMR) stake by 20% in Q2 2026, buying an estimated $646K and bringing the position to 961,083 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Dimensional Fund Advisors first reported a position in LRMR in Q4 2015 and has held it in 36 quarters since. The position peaked at $10.3M in Q3 2018. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Dimensional Fund Advisors held 961,083 shares of Larimar Therapeutics worth $2.93M as of Q2 2026.
  • Dimensional Fund Advisors bought 162,621 Larimar Therapeutics shares in Q2 2026, an estimated $646K.
  • Larimar Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2651 holding.
  • Dimensional Fund Advisors first reported a position in Larimar Therapeutics in Q4 2015 and has held it in 36 quarters since.
  • Dimensional Fund Advisors's Larimar Therapeutics position peaked at $10.3M in Q3 2018.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.